<DOC>
	<DOCNO>NCT01926002</DOCNO>
	<brief_summary>The primary hypothesis study single dose MK-8351 reduce baseline early asthmatic response ( EAR ) assess area curve 0-3 hour ( AUC0-3hr ) force expiratory volume ( FEV1 ) compare placebo .</brief_summary>
	<brief_title>A Single-Dose Study MK-8351 Lung Allergen Challenge ( MK-8351-003 )</brief_title>
	<detailed_description>This randomize , placebo-controlled , 4-period study . Eligible patient undergo single-blind phase Period 1 , follow 3 period receive low-dose MK-8351 , high-dose MK-8351 , match placebo single dose random sequence crossover study design .</detailed_description>
	<criteria>Females nonchildbearing potential ( least 1 year postmenopausal , posthysterectomy , postoophorectomy , tubal ligation ) ; Males female partner childbearing potential must agree use medically acceptable method contraception 120 day last dose study medication ; Body Mass Index ( BMI ) &gt; =17 kg/m^2 &lt; =33 kg/m^2 Nonsmoker nonuser nicotine nicotinecontaining product least 6 month prior enrollment ; History allergeninduced asthma least 6 month prior enrollment ; Able perform reproducible pulmonary function test ; Positive methacholine challenge test prior receive study medication ; Allergic response house dust mite allergen standardize cat pelt hair allergen extract ; Ability tolerate sputum induction produce adequate sputum . History clinically significant disease disorder ; History malignancy ; History significant multiple and/or severe allergy ; History milk lactose allergy intolerance ; History anaphylactic reaction significant intolerability prescription nonprescription drug food ; Positive human immunodeficiency virus ( HIV ) , hepatitis B surface antigen , hepatitis C antibody ; History major surgery within 3 month prior enrollment ; Participation another investigational trial within 4 week screen ; Lactating female ; Inability refrain , anticipate use , medication include herbal remedy trial period ; History receive antiimmunoglobulin E ( IgE ) immunotherapy ; History serious allergy drug history hypersensitivity inhale salbutamol , antihistamine , potential asthma/anaphylaxis rescue medication ; History hospitalization asthmarelated illness within 3 month screen ; History emergent care twice last 12 month asthmarelated illness ; History lifethreatening asthma ; Consumes &gt; 4 glass alcoholic beverage per day ; Consumes &gt; 6 serving coffee , tea , cola , energy drink caffeinated beverage per day ; History current use illicit drug within past 24 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>